ConductScience.org, home

Paper · 38017477

miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability.

Liu Y and 6 others. Cancer Cell Int, 2023. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability. Papers, record 38017477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38017477

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability.
PubMed
Journal
Cancer Cell Int
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.92
iCite
Revised in PubMed
2023-12-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YYing
2Jin AAihua
3Quan XXianglan
4Shen XXionghu
5Zhou HHoukun
6Zhao XXingyu
7Lin ZZhenhua

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JJKH20220554KJProject of The Education Department of Jilin ProvincePubMed
210101207This research was supported by the Projects of Science and Technology Department of Jilin ProvincePubMed
20210101423JCThis research was supported by the Projects of Science and Technology Department of Jilin ProvincePubMed
82360576The National Natural Science Foundation of ChinaPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,650,758An integrative pan-cancer analysis reveals the carcinogenic effects of NCAPH in human cancer.Math Biosci Eng2023https://conductscience.org/library/papers/36650758PubMed
234,216,688Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis.Cancer Lett2021https://conductscience.org/library/papers/34216688PubMed
334,758,330TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change.Cell Rep2021https://conductscience.org/library/papers/34758330PubMed
435,310,934miR-590-5p Overexpression Alleviates β-Amyloid-Induced Neuron Damage via Targeting Pellino-1.Anal Cell Pathol (Amst)2022https://conductscience.org/library/papers/35310934PubMed
535,398,344Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment.Gastroenterology2022https://conductscience.org/library/papers/35398344PubMed
636,734,882MiR-181a-5p promotes osteogenesis by targeting BMP3.Aging (Albany NY)2023https://conductscience.org/library/papers/36734882PubMed
735,240,055Loss-of-function variants in TIAM1 are associated with developmental delay, intellectual disability, and seizures.Am J Hum Genet2022https://conductscience.org/library/papers/35240055PubMed
832,591,905Structure, function and regulation of mammalian glucose transporters of the SLC2 family.Pflugers Arch2020https://conductscience.org/library/papers/32591905PubMed
936,519,542TIAM1-mediated synaptic plasticity underlies comorbid depression-like and ketamine antidepressant-like actions in chronic pain.J Clin Invest2022https://conductscience.org/library/papers/36519542PubMed
1037,392,283MiR-590-5p promotes cisplatin resistance via targeting hMSH2 in ovarian cancer.Mol Biol Rep2023https://conductscience.org/library/papers/37392283PubMed

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41,195,364Research Progress on the Regulation of Glycolysis in Gastric Cancer: Key Genes and Enzymes.Int J Gen Med2025https://conductscience.org/library/papers/41195364PubMed
41,051,622MicroRNA signatures of invasiveness in PitNETs: a focus on miR-186-5p, miR-191-5p, miR-454-3p, and miR-590-5p.Endocrine2025https://conductscience.org/library/papers/41051622PubMed
40,842,856Identification of Key Glycolysis-Related Genes in Osteoarthritis and Their Correlation with Immune Infiltration Using Bioinformatics Analysis and Machine Learning.Open Access Rheumatol2025https://conductscience.org/library/papers/40842856PubMed
40,579,785Decoding the pancreatic cancer microenvironment: The multifaceted regulation of microRNAs.Clin Transl Med2025https://conductscience.org/library/papers/40579785PubMed
40,471,218Implications of miRNA-590 dysregulation in digestive tract malignancies: mechanistic aspects and clinical significance.Mol Biol Rep2025https://conductscience.org/library/papers/40471218PubMed
40,419,852A prognostic model for head and neck squamous cell carcinoma based on radiotherapy sensitivity insights from nasopharyngeal carcinoma.Discov Oncol2025https://conductscience.org/library/papers/40419852PubMed
39,974,379Development and validation of a prognostic model based on disulfidptosis-related ferroptosis genes: DRD4 and SLC2A3 as biomarkers for predicting prognosis in colon cancer.Transl Cancer Res2025https://conductscience.org/library/papers/39974379PubMed
39,684,631HOXA11-As Promotes Lymph Node Metastasis Through Regulation of IFNL and HMGB Family Genes in Pancreatic Cancer.Int J Mol Sci2024https://conductscience.org/library/papers/39684631PubMed

Genes23

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38017477

GET https://conductscience.org/api/papers/v1/38017477/references?page=2